Technical Information
Cremophor ® ELP
May 2007 Supersedes issue dated November 2005 MEMP 030712e-05/Page 1 of 4
® = Registered trademark of BASF Aktiengesellschaft
Solubiliser for the pharmaceutical industry
Excipients s Contract Manufacturing Value Added
MEMP 030712e-05 May 2007
Page of 4
Cremophor ELP
Cremophor ELP, a purified grade of Cremophor EL was specially developed for sensi tive active ingredients, as the higher purity was found to improve their stability.
Chemical nature Like Cremophor EL, Cremophor ELP is a nonionic solubiliser made by reacting castor oil with ethylene oxide in a molar ratio of 1 : 35. This is followed by a purification process. Description Unlike Cremophor® EL, Cremophor ELP is a white to yellowish paste or cloudy liquid. It has to fulfill more exacting requirements with regard to water content, potassium ions and free fatty acids, particularly ricinoleic, oleic and palmitic acids. On heating, the last solid constituents melt at 26 °C to yield a clear oily liquid with a weak but characteristic odour. The HLB value lies between 12 and 14. The critical micelle concentration (CMC) lies at approx. 0.02%. Pharmacopœias Cremophor ELP meets the requirements of the current Ph.Eur. Monograph, “Macrogolglycerol Ricinoleate”. It also conforms to the latest monograph, “Polyoxyl 35 Castor Oil”. Solubility Cremophor ELP forms clear solutions in water and also dissolves in a wide range of organic solvents, such as ethanol, n-propanol, isopropanol, ethyl ace tate, chloroform, carbon tetrachloride, trichloroethylene, toluene and xylene. Specification
Appearance Identification Alkalinity Saponification value Acid value Hydroxyl value Iodine value Water pH (10% in water) Ethylene oxide 1,4-dioxane Clarity (10 % in water) Colour (10 % in water) Density (25 °C) Viscosity (25 °C) Sulphated ash (USP-NF) Ash (Ph.Eur.) Heavy metals Potassium Free fatty acids (C12–C18) (GC) Ricinoleic acid (HPLC) Oleic acid (HPLC) Palmitic acid (HPLC)
White to slightly yellowish paste Conforms Conforms 65–70 2.0 65–78 25–35 0.5% 5.0 – 7.0 1 10 ppm Conforms max. BY6 1.05–1.06 g/ml 600–750 mPa · s 0.2 % 0.2 % 10 ppm 15 ppm 1.0% 0.2% 0.1% 0.1%
MEMP 030712e-05 May 2007
Page of 4
Residual solvents (Ph. Eur. 5.4):
Microbiological Status (Cat. 2 + 3 a)
Cremophor ELP
Only the Class ll solvents, ethylene glycol, and 1,4-dioxane, and Class III solvents are likely to be present. Residual ethylene glycol is below the Option 1 limit of 620 ppm. Residual 1,4 dioxane is below the Option 1 limit of 380 ppm and is separ ately specified. Residual Class III solvents are below 0.5%. Conforms
Unless otherwise indicated, the methods used to determine the figures quotedabove are those given in the Ph.Eur. monograph, “Macrogolglycerol Ricinoleate” and USP-NF monograph, “Polyoxyl 35 Castor Oil”. Applications One possible field of application that can be considered for Cremophor ELP is in parenteral dosage forms. Thus Cremophor ELP is suitable for particularly demanding formulations, which prove not to achieve the desired stability when Cremophor EL is used. For other injectables, we recommend Solutol® HS 15 as a solubiliser. For further information, please see the Technical Data Sheets for Cremophor EL and Solutol HS 15. Toxicology No toxicological studies have been carried out on Cremophor ELP itself. Please refer to the toxicological findings for Cremophor EL. PBG-Number
10205104
PRD-Number
30035162
Packaging
60-kg removable-head steel drum with a Lupolen® inliner with its own lid.
Storage Cremophor ELP should be stored in tightly closed containers protected from light. Prolonged storage is not recommended unless the containers are completely full. Shelf life Cremophor® ELP is stable for at least 24 months if stored in the unopened original containers at room temperature (max. 25 °C). Safety Data Sheet
A Safety Data Sheet is available for Cremophor ELP.
Note The data contained in this publication are based on our current knowledge and experience. In view of the many factors that may affect processing and application of our product, these data do not relieve processors from carrying out their own investigations and tests; neither do these data imply any guarantee of certain properties, nor the suitability of the product for a specific purpose. Any descriptions, drawings, photographs, data, proportions, weights etc. given herein may change without prior information and do not constitute the agreed contractual quality of the product. It is the responsibility of the recipient of our products to ensure that any proprietary rights and existing laws and legislation are observed. May 2007
MEMP 030712e-05 May 2007
BASF Aktiengesellschaft
Page of 4
Fine Chemicals Division - Pharma Solutions - 67117 Limburgerhof - www.pharma-solutions.basf.com
Cremophor ELP